164 related articles for article (PubMed ID: 36030528)
1. Clinical triad with multi-biopsy histopathology as a reliable diagnostic marker of mycetomas: a retrospective review from a tertiary care center.
Ansari F; Singh S; Bhardwaj A; Budania A; Bains A; Nalwa A; Khera S; Elhence P; Patel A; Yadav T; Khera P
Int J Dermatol; 2023 Jan; 62(1):88-96. PubMed ID: 36030528
[TBL] [Abstract][Full Text] [Related]
2. Reporting of mycetoma cases from skin and soft tissue biopsies over a period of ten years: A single center report and literature review from Pakistan.
Zeeshan M; Fatima S; Farooqi J; Jabeen K; Ahmed A; Haq A; Arif MO; Zafar A
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010607. PubMed ID: 35905141
[TBL] [Abstract][Full Text] [Related]
3. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
Mekoguem C; Triboulet C; Gouveia A
J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
[TBL] [Abstract][Full Text] [Related]
4. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.
Karrakchou B; Boubnane I; Senouci K; Hassam B
BMC Dermatol; 2020 Jan; 20(1):1. PubMed ID: 31918687
[TBL] [Abstract][Full Text] [Related]
5. Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis.
Bonifaz A; Saldaña M; Araiza J; Mercadillo P; Tirado-Sánchez A
Rev Inst Med Trop Sao Paulo; 2017; 59():e55. PubMed ID: 28793023
[TBL] [Abstract][Full Text] [Related]
6. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
[TBL] [Abstract][Full Text] [Related]
7. [Mycetoma: 130 cases].
Dieng MT; Sy MH; Diop BM; Niang SO; Ndiaye B
Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):16-9. PubMed ID: 12605151
[TBL] [Abstract][Full Text] [Related]
8. The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents.
Siddig EE; Mhmoud NA; Bakhiet SM; Abdallah OB; Mekki SO; El Dawi NI; Van de Sande W; Fahal AH
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007056. PubMed ID: 31465459
[TBL] [Abstract][Full Text] [Related]
9. Comparing the performance of the common used eumycetoma diagnostic tests.
Siddig EE; Nyuykonge B; Mhmoud NA; Abdallah OB; Bahar MEN; Ahmed ES; Nyaoke B; Zijlstra EE; Verbon A; Bakhiet SM; Fahal AH; van de Sande WWJ
Mycoses; 2023 May; 66(5):420-429. PubMed ID: 36583225
[TBL] [Abstract][Full Text] [Related]
10. Head and neck mycetoma: Clinical findings, investigations, and predictors for recurrence of the disease in Sudan: A retrospective study.
Omer AT; Hasabo EA; Bashir SN; El Hag NE; Ahmed YS; Abdelgadir II; Osman AA
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010838. PubMed ID: 36251632
[TBL] [Abstract][Full Text] [Related]
11. Mycetoma caused by Madurella mycetomatis: a completely neglected medico-social dilemma.
van Belkum A; Fahal A; van de Sande WW
Adv Exp Med Biol; 2013; 764():179-89. PubMed ID: 23654067
[TBL] [Abstract][Full Text] [Related]
12. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
[TBL] [Abstract][Full Text] [Related]
13. Mycetoma due to
Sigera LSM; Narangoda KUL; Dahanayake MY; Shabri ULF; Malkanthi MA; Somarathne V; Jayasekera PI; Kolambage HALP
IDCases; 2020; 21():e00857. PubMed ID: 32528849
[TBL] [Abstract][Full Text] [Related]
14. Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.
Nenoff P; van de Sande WW; Fahal AH; Reinel D; Schöfer H
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1873-83. PubMed ID: 25726758
[TBL] [Abstract][Full Text] [Related]
15. Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by Madurella mycetomatis.
Nyuykonge B; Siddig E; Mhmoud NA; Bakhiet S; Zijlstra E; Verbon A; Fahal AH; van de Sande WWJ
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):783-786. PubMed ID: 36201367
[TBL] [Abstract][Full Text] [Related]
16. Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.
Ahmed SA; van de Sande WW; Desnos-Ollivier M; Fahal AH; Mhmoud NA; de Hoog GS
J Clin Microbiol; 2015 Oct; 53(10):3280-5. PubMed ID: 26246484
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous facial mycosis in a child due to Madurella mycetomatis.
Mirza SH; Gardezi AH; Khan Y; Wiqar MA
J Pak Med Assoc; 2007 Sep; 57(9):466-8. PubMed ID: 18072643
[TBL] [Abstract][Full Text] [Related]
18. Use of immunoblotting in testing Madurella mycetomatis specific antigen.
ELbadawi HS; Mahgoub E; Mahmoud N; Fahal AH
Trans R Soc Trop Med Hyg; 2016 May; 110(5):312-6. PubMed ID: 27198216
[TBL] [Abstract][Full Text] [Related]
19. Mycetoma: a unique neglected tropical disease.
Zijlstra EE; van de Sande WWJ; Welsh O; Mahgoub ES; Goodfellow M; Fahal AH
Lancet Infect Dis; 2016 Jan; 16(1):100-112. PubMed ID: 26738840
[TBL] [Abstract][Full Text] [Related]
20. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
